{
  "docId": "019de077-880d-703f-ad59-c0ee1df8dfeb",
  "docSlug": "3a2edb97bafa9f0a0205c3f0e878214f",
  "documentTitle": "Legend Biotech | Investor Presentation Deck | 26 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2025-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 26,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "other",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a two-column layout to categorize facilities by region (US vs EU).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-880d-703f-ad59-c0ee1df8dfeb/14",
  "deckHref": "/decks/019de077-880d-703f-ad59-c0ee1df8dfeb",
  "deckJsonHref": "/decks/019de077-880d-703f-ad59-c0ee1df8dfeb.json",
  "deckAnchorHref": "/decks/019de077-880d-703f-ad59-c0ee1df8dfeb#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.94,
        "x": 0.03,
        "y": 0.84
      },
      "kind": "callout",
      "text": "Current Median Turn Around Time is 32 Days",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4abacee-dbd8-422a-883e-55e4a8f5ba13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.25,
        "x": 0.04,
        "y": 0.27
      },
      "kind": "image",
      "text": "Raritan, NJ facility photo",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e8d53f0-52cc-45f0-a3f5-299fd51c1621",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.25,
        "x": 0.51,
        "y": 0.55
      },
      "kind": "image",
      "text": "Ghent Obelisc facility photo",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43fbb5ee-4f02-41fc-a750-cdf7349c333a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.25,
        "x": 0.04,
        "y": 0.55
      },
      "kind": "image",
      "text": "Morris Plains, NJ facility photo",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c6c34c0-619f-4fe1-95ad-bdf2c1ff9e11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.25,
        "x": 0.51,
        "y": 0.27
      },
      "kind": "image",
      "text": "Ghent Tech Lane facility photo",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d16ef9bb-8bf7-434a-9ba3-b9c3cdba6c3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.18,
        "x": 0.3,
        "y": 0.27
      },
      "kind": "list",
      "text": "Raritan, NJ: US/EU/JP/ROW Launch/Commercial Site for CARVYKTI. GMP Operational. Approval of new Raritan section expected in 2H25.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b0810ed-4992-4e06-b872-125e6c14643f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.18,
        "x": 0.77,
        "y": 0.55
      },
      "kind": "list",
      "text": "Ghent, Belgium: Obelisc. Commercial Site for CARVYKTI. Clinical production started Jan 2024 and commercial production started Sept 2024.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6bcf0a47-0870-487f-8f51-a5a022195e23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.18,
        "x": 0.77,
        "y": 0.27
      },
      "kind": "list",
      "text": "Ghent, Belgium: Tech Lane. Future Site for CARVYKTI. Clinical production expected in 1Q25 and commercial production expected in 4Q25.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a90b48b-fcd5-494d-ad6f-172952009f15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.18,
        "x": 0.3,
        "y": 0.55
      },
      "kind": "list",
      "text": "Morris Plains, NJ: Novartis CMO Site. Clinical production started July 2024 and commercial production started 1Q25.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0c9dbaa-ec5d-4590-8a32-984792196b47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "US FACILITIES",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75397756-b1d5-4cf9-b553-1e72a1ed949b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.51,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "EU FACILITIES",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a06557ce-8cdd-44a6-aefc-78dbde6ae6a1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Expanding to Meet Growing Global Demand",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "489f6bb0-939b-4513-b8ed-d061b2072c18",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Global Manufacturing Footprint",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b68ac6e-89f3-4ef5-b69e-d2ec3c67da0c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "fe0cffd5-2145-4362-a12e-cb4445ebbca8",
      "evidence": "list/bullet: Ghent, Belgium: Obelisc. Commercial Site for CARVYKTI. Clinical production started Jan 2024 and commercial production started Sept 2024.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 25,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "6b23062f-1e91-4b0d-ab29-cd4f465a9867",
      "evidence": "The deck presents a clear narrative around CARVYKTI's achievements and future potential, aligning with the Golden Circle framework.",
      "position": 1,
      "objective": "Show how CARVYKTI and Legend Biotech's pipeline align with the why, what, and how of transforming cancer care",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}